Victoria should implement a new report's recommendation to allow peers to distribute clean injecting equipment, but it needs to go further to ensure safe drug use in prison.
If England eliminates hepatitis C, it will be the first country to do so. But how feasible is it?
HIV has no boundaries. Men and women in almost every country are affected. Yet strides have been made, so much so that many are able to think of living with AIDS rather than dying from it.
Maybe it's time the government listened to the advice offered by its Advisory Council on the Misuse of Drugs.
Gonorrhoea has seen a sharp increase in diagnosis rates, of up to 94% in some groups.
Hepatitis viruses are serious infections that damage the liver. There is an urgent need to deal with increased Hepatitis B infections in Kenya.
HIV, STIs and other dangerous infections are feeding off of the opioid epidemic, creating an even more complicated threat to public health.
NSW has changed its laws imposing criminal penalties on someone with an STI who doesn't take "reasonable precautions" to not infect their sexual partner.
Australia has been subsidising drugs to cure hepatitis C since March 2016. Unlike in many other countries, these are available to everyone with the disease and are much cheaper for our government.
Why is it only some viruses are transmissible by blood, and how does the virus actually move from person to person?
While other cancer rates fall or remain static, liver cancer is on the rise. Here's why we need to start paying attention.
The newer drugs for hepatitis C might mean fewer people are diagnosed with liver cancer.
A promising new immunotherapy to treat liver cancer has been discovered.
The annual surveillance report of sexually transmissible infections and blood borne viruses in Australia has found notifications of sexually transmissible infections are on the rise in Australia.
Developing brand new treatments and cures isn't the only way to achieve a major reduction in cancer deaths worldwide.
Ghana must urgently implement strategies to tackle the high burden of viral hepatitis if it's to fulfill global targets of eliminating the disease by 2030.
Combinations of two or three hepatitis C virus direct-acting antiviral drugs taken for 8-24 weeks can cure more than 90% of people treated.
Hepatitis A, B, C, D and E are very different viruses. Hepatitis A is genetically closer to the common cold than it is to hepatitis B. Hepatitis C is closer to the virus that causes dengue fever.
Worldwide, around 30 million people enter and leave prison each year. Of these people, around 4.5 million have hepatitis C, almost 1 million have HIV and 1.5 million have hepatitis B infections.
With use of drugs such as ice on the rise, drug consumption rooms are now being set up in Europe to provide supervised inhalation.